Earnings call transcript: Hagerty tops Q3 2026 estimates and lifts outlook

Hagerty beat Q3 forecasts with adjusted EPS of $0.10 versus $0.01 expected and revenue of $354.24 million versus $338.85 million, while shares rose 7.77% to $17.13 premarket. Written premiums increased 16% in the quarter, and the company raised 2026 guidance to $48–$60 million in GAAP net income and $305–$315 million in adjusted EBITDA. The outlook includes a $52 million acquisition-cost capitalization benefit that management said will not recur in 2027; marketplace revenue fell 6% in the quarter.

Analysis

The earnings quality is more mixed than the headline beat: 2026 profitability benefits from both a $52 million acquisition-cost timing item and favorable loss estimates, including a $26 million current-year release in Q3. The key 2027 test is whether policy growth, retention and expense leverage can offset those non-repeatable supports without a material deterioration in loss picks. Premium growth driven by policy count is more durable than rate-led growth, but reported revenue is a noisy signal during the Markel fronting transition and should not be read as a clean organic growth measure.

At roughly 85x P/E and near its 52-week high, HGTY appears priced for continued execution; the next catalyst is 2027 guidance, not another quarterly beat. State Farm conversions and agent productivity could extend customer acquisition, while Broad Arrow can act as a funnel into insurance and membership. But auction activity and collector-car values are cyclical: a pause in high-end prices could pressure marketplace economics and reduce the cross-sell tailwind. Higher insured values may also raise claim severity even if frequency stays favorable. AI productivity claims are promising, but current evidence supports efficiency gains—not yet a defensible moat.

Near term, seasonality and guidance could cool momentum after the sharp reaction. Over 6–18 months, the thesis depends on repeatable underwriting results and policy growth absorbing the accounting headwind. A weaker 2027 EBITDA bridge, worsening retention, adverse reserve development, or less favorable reinsurance pricing would falsify the premium-growth narrative.

Key Decisions for Investors

• Do not chase the premarket gap. For existing HGTY longs, consider trimming into strength or using a covered call only if willing to sell; the valuation leaves limited room for an earnings-quality disappointment.
• Treat a tactical short as a conditional alert, not a base case: consider it only if HGTY closes back below the prior $15.89 close after failing to hold the $17.15 area; a sustained move above $17.15 invalidates the setup. Check borrow and option pricing before implementation.
• At the next results, focus on a 2027 EBITDA bridge excluding the $52 million timing benefit, loss-ratio development excluding reserve releases, policy-in-force additions, retention, and the cost and pace of State Farm conversions.
• Monitor collector-car auction sell-through and pricing, marketplace revenue mix, and reinsurance renewal terms. A cooling high-end market alongside rising claim severity would weaken the ecosystem and underwriting cases.